Building an Italian test of famous-face recognition for people with stroke or dementia
Develops a test of recognizing famous faces in people with dementia or stroke.
Plain-language title generated from the registry record
Registry title: Development, Validation and Normative Data of the Italian Battery for the Recognition of Famous Faces (FAME)
Key facts
- Where
- Bari, Castel Goffredo, Lumezzane, Milan, Mistretta, Montescano, Pavia, Sciacca, Telese Terme, and Veruno, ItalySee the 10 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 85 years old?
Source: NCT07911878, who can take part
Where in Italy
- Istituti Clinici Scientifici Maugeri IRCCS BariBari, ItalyTaking people
- IRCCS Maugeri Castel GoffredoCastel Goffredo, ItalyNot yet recruiting
- IRCCS Maugeri LumezzaneLumezzane, ItalyTaking people
- Istituti Clinici Scientifici Maugeri IRCCS, MilanoMilan, ItalyTaking people
- ICS Maugeri - MistrettaMistretta, ItalyTaking people
- IRCCS Maugeri MontescanoMontescano, ItalyTaking people
- IRCCS Maugeri PaviaPavia, ItalyTaking people
- ICS Maugeri SciaccaSciacca, ItalyTaking people
- IRCCS Maugeri Telese TermeTelese Terme, ItalyTaking people
- IRCCS Maugeri VerunoVeruno, ItalyNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Istituti Clinici Scientifici Maugeri SpA
- Trial code
- NCT07911878
- Record updated
- 3 November 2026
- Original description
The I-FACE project aims to develop and validate a battery to assess famous-face recognition in people with neurodegenerative diseases and stroke. It will examine face naming, familiarity, and semantic knowledge, establish norms for the Italian population, and test how well the measures identify recognition difficulties in patients with frontotemporal dementia, Alzheimer's disease, and stroke.Read full original descriptionShow less
Sviluppo, Validazione e Dati Normativi Della Batteria Italiana Per il Riconoscimento Dei Volti Famosi I-FACE
The I-FACE project aims to develop and validate a battery to assess famous-face recognition in people with neurodegenerative diseases and stroke. It will examine face naming, familiarity, and semantic knowledge, establish norms for the Italian population, and test how well the measures identify recognition difficulties in patients with frontotemporal dementia, Alzheimer's disease, and stroke.
Inclusion: Age 40-85 years. No chronic medical, neurological, or psychiatric conditions, or major depressive episode detected during screening; No history of schizophrenia or bipolar disorder in the 5 years prior to screening; Mini-Mental State Examination (MMSE) score ≥ 26; Diagnosis of probable FTD according to established clinical criteria. Age 40-85 years. Ability to provide informed consent; Diagnosis of probable AD according to established clinical criteria. Age 40-85 years. Ability to provide informed consent; Subacute phase: 1 week to 3 months post-event. Ischemic or hemorrhagic stroke confirmed by neuroimaging and/or clinical judgment.
Exclusion: History of previous stroke or multifocal stroke documented by imaging. Brainstem or cerebellar stroke. History of traumatic brain injury (TBI), seizures, brain tumors, neurodegenerative diseases, or psychiatric disorders; Uncorrected vision or hearing impairment; Frontotemporal Dementia (FTD) Patients; History of neurological diseases other than FTD (e.g., stroke, brain tumor, multiple sclerosis, traumatic brain injury); Uncorrected vision or hearing impairment. History of serious psychiatric diseases, developmental disorders (e.g., autism spectrum), or intellectual disability; Dementia severity (CDR) > 1; Alzheimer's Disease (AD) Patients; History of neurological diseases other than AD (e.g., stroke, brain tumor, multiple sclerosis, traumatic brain injury); Uncorrected vision or hearing impairment. History of serious psychiatric diseases, developmental disorders, or intellectual disability; Dementia severity (CDR) > 1; Post-Stroke Patients.
Healthy Controls (HC).